Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has expanded 51.8% YoY to 20.3x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 41.55 | — | — | 44.24 | 33.71 | 22.61 | 42.65 | 54.25 | 49.16 | 61.34 | — | 44.97 | 47.42 |
| — | — | — | -18.4% | -31.4% | -63.1% | — | +20.6% | +3.7% | +120.5% | — | +70.4% | +51.1% | |
| P/S Ratio | 1.15 | 1.73 | 1.46 | 1.97 | 1.81 | 1.79 | 1.85 | 1.90 | 2.08 | 2.72 | 2.25 | 2.29 | 2.75 |
| — | -3.6% | -21.1% | +3.7% | -13.1% | -34.1% | -17.9% | -17.1% | -24.2% | +26.8% | +20.8% | +29.4% | +8.9% | |
| P/B Ratio | 1.16 | 1.45 | 1.54 | 1.65 | 1.55 | 1.44 | 1.76 | 1.90 | 2.08 | 2.52 | 2.14 | 2.06 | 2.54 |
| — | +0.7% | -12.6% | -13.2% | -25.3% | -42.8% | -17.7% | -7.5% | -18.2% | -4.3% | -1.6% | -2.8% | -17.6% | |
| P/FCF | 14.71 | — | 14.10 | 20.67 | 9.40 | — | 19.74 | 16.28 | 12.98 | 164.18 | 14.18 | 24.88 | 16.68 |
| — | — | -28.6% | +27.0% | -27.6% | — | +39.3% | -34.6% | -22.1% | +378.4% | -12.0% | +10.8% | -35.0% | |
| EV / EBITDA | 12.52 | 20.28 | 14.78 | 12.59 | 11.77 | 13.36 | 19.66 | 18.47 | 19.16 | 23.91 | 116.12 | 18.74 | 18.48 |
| — | +51.8% | -24.8% | -31.8% | -38.6% | -44.1% | -83.1% | -1.4% | +3.7% | +28.9% | +273.3% | +14.5% | +6.5% | |
| EV / EBIT | 16.00 | — | 22.75 | 15.51 | 14.55 | 17.38 | 19.52 | 24.62 | 22.94 | 27.19 | 177.42 | 20.80 | 20.32 |
| — | — | +16.6% | -37.0% | -36.5% | -36.1% | -89.0% | +18.4% | +12.9% | +19.6% | +266.3% | +23.7% | +1.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
U.S. Physical Therapy, Inc.'s operating margin was 7.6% in Q1 2026, down 3.3 pp QoQ and down 5.3 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of 12.3% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.1% | 19.9% | 20.7% | 22.5% | 25.4% | 20.4% | 18.7% | 17.3% | 20.3% | 18.2% | 19.7% | 18.6% | 21.3% |
| — | -2.1% | +10.6% | +29.7% | +25.2% | +11.6% | -5.3% | -6.9% | -4.7% | -12.2% | +0.0% | -3.0% | -3.0% | |
| Operating Margin | 10.3% | 7.6% | 10.9% | 15.4% | 15.2% | 12.9% | 8.1% | 8.8% | 9.3% | 9.6% | -0.6% | 10.6% | 13.2% |
| — | -41.0% | +34.7% | +76.0% | +63.1% | +34.3% | +1517.2% | -17.1% | -29.7% | -16.2% | -111.8% | -0.8% | -7.2% | |
| Net Margin | 1.9% | 3.1% | -5.2% | 4.4% | 5.4% | 6.5% | 4.1% | 3.3% | 4.1% | 4.2% | -5.1% | 4.7% | 5.3% |
| — | -52.8% | -226.2% | +34.2% | +30.4% | +52.9% | +180.6% | -29.6% | -22.6% | -16.3% | -562.7% | -30.3% | -34.1% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.0% | 0.6% | -1.4% | 0.9% | 1.2% | 1.3% | 1.0% | 0.8% | 1.0% | 1.0% | -1.2% | 1.1% | 1.4% |
| — | -50.2% | -230.6% | +13.4% | +12.7% | +30.7% | +186.7% | -22.1% | -27.4% | -35.8% | -423.4% | -47.5% | -42.7% | |
| ROA | 1.3% | 0.4% | -0.9% | 0.6% | 0.7% | 0.8% | 0.7% | 0.5% | 0.7% | 0.7% | -0.8% | 0.7% | 0.9% |
| — | -51.2% | -229.8% | +13.1% | +10.7% | +28.6% | +185.8% | -22.8% | -21.8% | -24.8% | -500.2% | -40.5% | -40.7% | |
| ROIC | 5.6% | 0.8% | 1.5% | 1.8% | 1.8% | 1.4% | 1.2% | 1.4% | 1.4% | 1.4% | -0.1% | 1.6% | 2.0% |
| — | -43.1% | +24.2% | +33.1% | +25.1% | +0.2% | +1495.7% | -12.1% | -27.5% | -15.3% | -112.1% | -5.1% | -11.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
U.S. Physical Therapy, Inc.'s Debt/EBITDA ratio is 20.0x, up from 16.0x last quarter — elevated, raising questions about debt serviceability.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.55 | 0.46 | 0.55 | 0.39 | 0.40 | 0.40 | 0.39 | 0.38 | 0.39 | 0.38 | 0.40 | 0.39 | 0.40 |
| — | +14.5% | +42.2% | +3.9% | +3.2% | +6.1% | -1.9% | -2.7% | -3.0% | -38.4% | -35.0% | -31.0% | -30.4% | |
| Debt / EBITDA | 4.14 | 20.00 | 15.98 | 9.90 | 9.85 | 12.05 | 14.60 | 13.29 | 12.90 | 13.48 | 79.98 | 13.12 | 10.93 |
| — | +66.0% | +9.5% | -25.6% | -23.6% | -10.6% | -81.7% | +1.3% | +18.0% | -6.5% | +186.7% | -7.7% | -2.3% | |
| Current Ratio | 1.01 | 1.19 | 1.01 | 1.20 | 1.18 | 1.17 | 1.18 | 1.78 | 1.88 | 2.16 | 2.28 | 2.77 | 2.82 |
| — | +1.0% | -14.9% | -32.3% | -37.2% | -45.6% | -48.2% | -36.0% | -33.2% | +66.3% | +75.5% | +100.3% | +96.8% | |
| Quick Ratio | 1.01 | 1.19 | 1.01 | 1.20 | 1.18 | 1.17 | 1.18 | 1.78 | 1.88 | 2.16 | 2.28 | 2.77 | 2.82 |
| — | +1.0% | -14.9% | -32.3% | -37.2% | -45.6% | -48.2% | -36.0% | -33.2% | +66.3% | +75.5% | +100.3% | +96.8% | |
| Interest Coverage | 9.23 | 4.47 | 7.36 | 10.50 | 10.35 | 8.60 | 9.94 | 7.11 | 8.47 | 8.50 | 1.05 | 8.51 | 8.25 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying USPH stock.
U.S. Physical Therapy, Inc.'s current P/E is 41.5x. The average P/E over the last 2 quarters is 39.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
U.S. Physical Therapy, Inc.'s current operating margin is 10.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking U.S. Physical Therapy, Inc.'s business trajectory between earnings reports.